Learn more

G2M CANCER DRUGS AG

Overview
  • Total Patents
    18
About

G2M CANCER DRUGS AG has a total of 18 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are NAKAO KAZUWA, SUPERLAB FAR EAST LTD and LANG FLORIAN.

Patent filings per year

Chart showing G2M CANCER DRUGS AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Minucci Saverio 11
#2 Pelicci Pier Giuseppe 11
#3 Hentsch Bernd 10
#4 Heinzel Thorsten 7
#5 Maurer Alexander B 6
#6 Goettlicher Martin 5
#7 Groner Bernd 4
#8 Wels Winfried Stephan 4
#9 Golebiewski Martin 4
#10 Zhu Ping 4

Latest patents

Publication Filing date Title
US2005176686A1 Novel compounds as histone deacetylase inhibitors
EP1491188A1 Topical use of valproic acid for the prevention or treatment of skin disorders
EP1403639A1 Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases
EP1400806A1 The use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity
EP1293205A1 Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease